Craft

Yiling Pharmaceutical

Stock Price

¥17.3

2024-10-29

Market Capitalization

¥28.5 B

2024-10-29

Revenue

¥7.7 B

FY, 2025

Yiling Pharmaceutical Summary

Company Summary

Overview
Shijiazhuang Yiling Pharmaceutical (石家庄以岭药业股份有限公司) is a company that develops, produces, and sells medicine. It offers drugs for coronary heart disease, brain infarction, arrhythmia, chronic heart failure, cold, influenza, diabetes, and other major diseases.
Type
Public
Status
Active
Founded
1992
HQ
Shijiazhuang, CN | view all locations
Website
https://en.yiling.com/
Cybersecurity rating
Sectors

Key People

  • Wu Xiangjun

    Wu Xiangjun, Chairman

    • Wu Yiling

      Wu Yiling, Founder

      LocationsView all

      1 location detected

      • Shijiazhuang, He Bei Sheng HQ

        China

        No. 238, Tianshan Street, High-tech Development Zone,

      Yiling Pharmaceutical Financials

      Summary Financials

      Revenue (Q1, 2026)
      ¥2.4B
      Gross profit (Q1, 2026)
      ¥1.4B
      Net income (Q1, 2026)
      ¥408.6M
      Cash (Q1, 2026)
      ¥784.0M
      EBIT (Q1, 2026)
      ¥486.5M
      Enterprise value
      $27.7B

      Footer menu